Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
87.3M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
2.73M
-
Shares change
-
+415K
-
Total reported value, excl. options
-
$22.7M
-
Value change
-
+$3.52M
-
Put/Call ratio
-
0.82
-
Number of buys
-
15
-
Number of sells
-
-18
-
Price
-
$8.35
Significant Holders of Immunome Inc. - COMMON STOCK (IMNM) as of Q3 2023
48 filings reported holding IMNM - Immunome Inc. - COMMON STOCK as of Q3 2023.
Immunome Inc. - COMMON STOCK (IMNM) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.73M shares
of 87.3M outstanding shares and own 3.13% of the company stock.
Largest 10 shareholders include Point72 Asset Management, L.P. (546K shares), VANGUARD GROUP INC (396K shares), Alpine Global Management, LLC (366K shares), Alpine Global Management, LLC (366K shares), PRICE T ROWE ASSOCIATES INC /MD/ (174K shares), TD Asset Management Inc (127K shares), Prentice Capital Management, LP (112K shares), BANK OF MONTREAL /CAN/ (92.6K shares), GEODE CAPITAL MANAGEMENT, LLC (84.7K shares), and MANUFACTURERS LIFE INSURANCE COMPANY, THE (53.7K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.